Article

Dr. Joshua Bershad Discusses RWJUH's Stance on Clinical Pathways

Dr. Joshua Bershad, Senior Vice President, Medical Affairs and Chief Medical Officer, Robert Wood Johnson University Hospital, New Brunswick, NJ, discusses why evidence-based medicine, proper technologies and tracking protocols must be in place for clinical pathways to be effective from a managed care perspective.

Dr. Bershad also explains that RWJUH makes it a practice to invest in the latest surgical technologies because it leads to better quality of care and less time in the hospital, which provides the opportunity to reduce costs.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo